3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Burkitt Lymphoma
5
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Philadelphia Chromosome
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia
1
Glioma
1
Interventions
X-Rays
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Vincristine
5
Nuclear Medicine Department, Hospital
5
Biopsy
5
Doxorubicin
4
Etoposide
3
Dactinomycin
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
Radiotherapy, Conformal
2
Radiotherapy
2
Radiation
2
LY3023414
2
Irinotecan
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Dasatinib
×
90 days
×
Clear all
No trials found.